I]-15-(q-iodophenyl)-3-R,S-methylpentadecanoic acid ([
125 I]-BMIPP). These analogues are taken up like native fatty acids, but once inside the cell do not directly enter b-oxidation. Rather, they become trapped in the slower processes of x and a-oxidation. Study aims were to (1) . Both analogues are taken up by tissues like native substrates however, once inside the cell, they become trapped in various stages of x or a-oxidation. As a result, the analogues remain in the tissue allowing their quantification by specific activity.
Developed and extensively tested by Oakes et al. [8] , [ 3 H]-BROMO shows excellent retention in the majority of tissues examined. Studies employing this tracer were the first to effectively show increased efficiency of tissue LCFA uptake in a model of dietary induced insulin resistance [9] . BMIPP was developed by Knapp et al. [10] [11] [12] and has been primarily used for cardiac imaging with an [ 123 I] label. Using single photon emission computed tomography (SPECT) defects in fatty acid uptake by the heart are imaged and are indicative of ischemia or tissue injury [5, [13] [14] [15] . Like [ 3 H]-BROMO, the tracer has also proven to be a powerful tool in evaluating various pharmacological treatments on cardiac metabolism [16] [17] [18] [19] .
To date, numerous studies have individually assessed the metabolism of these fatty acid tracers in vivo and some comparisons between different tracers have been reported [1] 
Experimental Methods

Animals
Male Sprague-Dawley rats (Harlan Industries, Indianapolis, IN) were housed individually and maintained at 23°C on a 0600-1800 hours light cycle. Rats were fed standard chow ad libitum (Purina, Nestlé, St Louis, MI) and given free access to water. The rats were housed under these conditions for *1 week, by which time their weights had reached *330 g. Following weight gain, rats were randomly divided into rest and exercise groups (n = 8 per group). All procedures were approved by the Vanderbilt University Animal Care and Use Subcommittee and followed National Institutes of Health guidelines for the care and use of laboratory animals.
Surgical Procedures
Surgical procedures were performed as previously described for arterial and venous catheterizations [20] . Briefly, animals were anaesthetized with a 50:5:1 vol/vol/vol mixture of ketamine, rompun, and acepromazine, and the left common carotid artery and right jugular vein were catheterized with PE50 catheters, which were exteriorized and secured at the back of the neck, filled with heparinized saline (150 U/ml), and sealed with a stainless steel plug. Immediately post-surgery, each animal received 75 mg/kg of ampicillin subcutaneously to prevent infection. After surgery, animal weights and food intake were monitored daily.
Isotopic Analogues 125 I]-BMIPP, the administered dose was volumetric. A dose of 100 ll was administered and the activity of the tracer was determined for each individual animal and corrected for any decay. To limit tracer decay, all studies were performed within 30 days of synthesis.
[ 3 H]-BROMO was prepared by American Radioactive Chemicals Co (St Louis, MO) from palmitic acid as previously described [8] . The final concentration was 1 lCi/ll. On the day of the experiment, 20 ll of [ 3 H]-BROMO was evaporated and reconstituted in 100 ll of saline containing 0.35 mg/ml rat albumin (Sigma Chemical, St Louis, MO). This solution was added to 100 ll of [ 125 I]-BMIPP in ursodeoxycholic acid. In total, [ 3 H]-BROMO, 19.5 lCi was administered to each animal. On the day of the experiment, 5 ll of infusate was retained for normalization of radioactivity while the remaining 195 ll was administered to the animal.
Resting Studies
On the morning of the study, rats were fasted for 5 h in a clear Tupperware (2 l) container lined with bedding. Approximately 1 h prior to the experiment, catheters were flushed with heparinized saline (10 U/ml) and connected to PE50 and Silastic tubing for infusions and sampling. Rats were then placed in the Tupperware container until the commencement of the experimental protocol. Throughout the experimental protocol rats were conscious and unrestrained. In total the experimental protocol was 40 min in duration. Prior to tracer infusions, a basal blood sample were obtained (100 ll) for the measurement of isotopic analogues, plasma glucose, insulin and nonesterified fatty acids (NEFA). To prevent declines in hematocrit, the erythrocytes taken prior to isotopic analogue infusion were washed in saline and re-infused shortly after each sample was taken. Following the final blood sample, rats were anesthetized with pentobarbital sodium and skeletal muscle (gastrocnemius), liver, heart, brain and epididymal fat were rapidly excised, rinsed in saline to remove excess blood, freeze clamped in liquid nitrogen and frozen at -80°C until further analysis.
Exercise Studies
Two days prior to the protocol, rats in this treatment were acclimated by running on a motorized treadmill for 10 min at 0.6 mi/h. On the morning of the study, rats were fasted for 5 h in a clear Tupperware (2 l) container lined with bedding. Approximately 1 h prior to the experiment, catheters were flushed with heparinized saline (10 U/ml) and connected to PE50 and silastic tubing for infusions and sampling. Rats were then placed in the treadmill until the commencement of the experimental protocol. Following basal blood sampling, rats were run on the treadmill at 0.6 mi/h and samples were obtained as in the resting protocol. This exercise intensity is moderate for rats. At 40 min, rats were anesthetized and tissue samples were obtained as previously described.
Plasma Analysis
Plasma NEFAs were measured spectrophotometrically by an enzymatic colorimetric assay (Wako NEFA C kit, Wako Chemicals Inc., Richmond, VA). Plasma glucose concentrations were measured by the glucose oxidase method using an automated glucose analyzer (Beckman Instruments, Fullerton, CA H radioactivity was counted after addition of fluor (10 ml; Ultimate Gold, Packard Bioscience, Boston, MA.) using a Packard Tri-Carb 2900TR Liquid Scintillation Analyzer (PerkinElmer, Boston, MA). In addition, plasma was also analyzed by thin layer chromatography (TLC) by methods that were derived from Kropp et al. [21] . Here, individual plasma time points were examined by TLC from a representative animal in each treatment group. TLC plates reflecting plasma samples were segmented into 1 cm sections and analyzed for tracer and tracer conversion products. Each plate was examined for radioactivity. Significant radioactivity appearing in minor lipid fractions over time was considered evidence of tracer breakdown, although the exact chemical nature of each product was not identified. Tracer conversion or breakdown was calculated as a ratio of total activity appearing on the plate for each time point.
Tissue Analysis
Total [
125 I] radioactivity in tissues was determined on sections of whole tissue (*100 mg) using a Beckman Gamma 5500 counter (Beckman Instruments, Fullerton, CA). Following this, total lipid was extracted from the tissue using a modified Folch-Lees extraction [22] . The [
125 I] radioactivity in this fraction was then reassessed before 10 ml of flour was added to samples and then 3 H radioactivity determined by liquid scintillation counting (Packard TRI-CARB 2900TR, Packard, Meriden, CT) with Ultima Gold (Packard) as scintillant. The relationship between gamma radioactivity and beta emissions using this specific process and counter has been previously established in our laboratory. This relationship was used to correct 3 H radioactivity for beta-emissions originating from [ 125 I] radioactivity in both tissue and plasma samples [3] . In addition, lipid was extracted from a portion of each tissue (*100 mg) from four rats in both the resting and exercise protocols using a Folch-Lees extraction [22] . Lipid fractions were then separated by TLC [23] . Plate segments were subsequently separated and individually counted. Tissues plates were separated based on lipid fraction (phospholipid, mono-diglyceride, free fatty acids and triglyceride).
Calculations
Plasma Kinetics
Identical equations were used for the determination of 
Tissue Kinetics
Rates of tissue LCFA clearance (K t , Eq. 4) and metabolic indices (R t , Eq. 5) were calculated from the accumulation of [ 125 I]-BMIPP and [ 3 H]-BROMO in tissues (t) relative to the integral of the plasma (p) concentration following the instantaneous bolus. These measurements follow from Eqs. 1-3 and have been previously described [3, 9] .
R t ¼ K t ½LCFAp ð5Þ
A one-way repeated measures analysis of variance (ANOVA) was performed to compare differences between [ 125 I]-BMIPP and [ 3 H]-BROMO within specific tissues. To determine differences over time for blood glucose and NEFA, a two-way repeated measures ANOVA was performed. To establish differences within ANOVA, a Tukey post hoc test was used. Significance levels of p B 0.05 were employed, and data are reported as means ± standard error of the mean (SEM).
Results
Animal Characteristics
Baseline animal characteristics for both rest and exercise experiments are outlined in Table 1 . Blood glucose remained stable in the rest group (7.7 ± 0.3 mM at 40 min) while it steadily increased in the exercise group to 11.5 ± 0.6 mM at the end of the protocol (p \ 0.05). Plasma NEFA levels remained stable with average values of 0.63 ± 0.06 mM and 0.56 ± 0.05 mM for rest and exercise studies at the end of the experimental protocol (p [ 0.05). All animals in the exercise protocol were able to successfully complete the required 40 min of exercise.
Metabolic Clearance and Uptake
Whole body metabolic clearance in the resting state was set to an arbitrary value of 1.0 for each tracer for comparison to the exercise treatment. Results show comparable increments in fatty acid clearance for each tracer with exercise ( Fig. 1) . Tissues (skeletal muscle, heart, liver, adipose tissue) were examined for rates of fatty acid uptake (R t , lmol/100 g/min). Absolute values are shown in Fig. 2 Fig. 3 . R 2 values for resting and exercise samples are plotted individually, and an aggregate value also presented. Results of individual muscle types for rest and exercise studies were at least moderately correlated, with aggregate R 2 values of 0.39, 0.55, 0.26, and 0.56 for the soleus, vastus lateralis, gastrocnemius and heart respectively. In contrast, data from liver and adipose tissue are poorly correlated between tracers with both treatments. (Table 2) .
Tracer Tissue Distribution
The intracellular fate of tracers were analyzed by TLC. Results demonstrated tracers to reside in three distinct fractions ( Table 3 ). The first fraction contained phospholipid, monoglyceride, and diglyceride (PL + MG + DG) while others analyzed free fatty acids (FFA), triglyceride (TG). Analysis showed the majority of radioactivity resided in the PL + MG + DG fraction followed by FFA and finally TG. Differences between tracer distributions were minimal. At rest, a lower fraction of 125 I]-BMIPP. Conceptually, both agents are regarded as ''generic'' long chain fatty acid tracers. The close agreement between these tracers in muscle tissue is reassuring in terms of this usual simplification. There may be tissue specific differences related to precise molecular structure of both fatty acids and fatty acid tracers that are reflected in the differences in adipose and liver. An increase in hepatic extraction and breakdown of [ 3 H]-BROMO compared to [ 125 I]-BMIPP may also play a role. Evidence of increased hepatic [ 3 H]-BROMO breakdown has been previously reported [8] . Intravenous administration of [ 3 H]-BROMO to rodents found liver to have a retention rate of only 77% compared to skeletal muscle that retained over 90% of tracer during 16 min of infusion [8] . Given these and the present findings, it is reasonable to hypothesize that [
125 I]-BMIPP retention rates may most closely reflect actual liver LCFA uptake. For epididymal fat, we show absolute rates of fatty acid uptake to be similar between tracers. However, correlation of individual animals between [
3 H]-BROMO and [
125 I]-BMIPP for this tissue yielded poor results. This discrepancy is likely due to the low rate of fatty acid uptake and tracer detection in this tissue.
To examine fractional conversion of each tracer by tissue, detailed analysis of tracer distribution in plasma over time was conducted by TLC. A known conversion product for [ 3 H]-BROMO is 3 H 2 O. Previous analysis of the tracer show conversion to be *5% of the dose at 16 min in sedentary rats [8] . This value compares favorably with the 125 I]-BMIPP is straightforward to label but requires specific precautions related to iodination, and currently must be performed in an institutional setting. Finally, in studies where multiple tracers are employed, there may be specific limitations related to other radioactive labeled compounds in concurrent use. These issues must be considered prior to commencing studies with either tracer.
In conclusion, this study directly compares isotopic analogs for the measurement of fatty acid kinetics in vivo. Results show both analogues are effective for the measurement of FFA uptake and clearance in plasma. We showed a high correlation between tracers for cardiac and skeletal muscle. However, in both the liver and adipose tissue, derived rates of uptake diverged depending on the specific tracer. As a result, studies employing these or other fatty acid tracers in these tissues must be interpreted with caution. Generally, technical considerations argue for [ 3 H]-BROMO. However, when studies are prolonged ([20 min) and employ experimental manipulations requiring elevated metabolism, we show the preferable analog to be [
125 I]-BMIPP due to its lower rates of tissue excretion. 
